Literature DB >> 27720483

The Calcium Channel Subunit Alpha2delta2 Suppresses Axon Regeneration in the Adult CNS.

Andrea Tedeschi1, Sebastian Dupraz1, Claudia J Laskowski1, Jia Xue2, Thomas Ulas2, Marc Beyer2, Joachim L Schultze3, Frank Bradke4.   

Abstract

Injuries to the adult CNS often result in permanent disabilities because neurons lose the ability to regenerate their axon during development. Here, whole transcriptome sequencing and bioinformatics analysis followed by gain- and loss-of-function experiments identified Cacna2d2, the gene encoding the Alpha2delta2 subunit of voltage-gated calcium channels (VGCCs), as a developmental switch that limits axon growth and regeneration. Cacna2d2 gene deletion or silencing promoted axon growth in vitro. In vivo, Alpha2delta2 pharmacological blockade through Pregabalin (PGB) administration enhanced axon regeneration in adult mice after spinal cord injury (SCI). As PGB is already an established treatment for a wide range of neurological disorders, our findings suggest that targeting Alpha2delta2 may be a novel treatment strategy to promote structural plasticity and regeneration following CNS trauma.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27720483     DOI: 10.1016/j.neuron.2016.09.026

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  77 in total

Review 1.  Emerging roles for α2δ subunits in calcium channel function and synaptic connectivity.

Authors:  William Christopher Risher; Cagla Eroglu
Journal:  Curr Opin Neurobiol       Date:  2020-06-07       Impact factor: 6.627

2.  Epigenetic regulator UHRF1 inactivates REST and growth suppressor gene expression via DNA methylation to promote axon regeneration.

Authors:  Young Mi Oh; Marcus Mahar; Eric E Ewan; Kathleen M Leahy; Guoyan Zhao; Valeria Cavalli
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-10       Impact factor: 11.205

3.  ADF/Cofilin-Mediated Actin Turnover Promotes Axon Regeneration in the Adult CNS.

Authors:  Andrea Tedeschi; Sebastian Dupraz; Michele Curcio; Claudia J Laskowski; Barbara Schaffran; Kevin C Flynn; Telma E Santos; Sina Stern; Brett J Hilton; Molly J E Larson; Christine B Gurniak; Walter Witke; Frank Bradke
Journal:  Neuron       Date:  2019-08-07       Impact factor: 17.173

Review 4.  Reconnecting Eye to Brain.

Authors:  Michael C Crair; Carol A Mason
Journal:  J Neurosci       Date:  2016-10-19       Impact factor: 6.167

Review 5.  Intra-axonal mechanisms driving axon regeneration.

Authors:  Terika P Smith; Pabitra K Sahoo; Amar N Kar; Jeffery L Twiss
Journal:  Brain Res       Date:  2020-04-28       Impact factor: 3.252

6.  Emerging molecular therapeutic targets for spinal cord injury.

Authors:  Shuo Wang; George M Smith; Michael E Selzer; Shuxin Li
Journal:  Expert Opin Ther Targets       Date:  2019-09-04       Impact factor: 6.902

7.  The Effect of Non-Gabapentinoid Anticonvulsants on Sensorimotor Recovery After Human Spinal Cord Injury.

Authors:  Freda M Warner; Catherine R Jutzeler; Jacquelyn J Cragg; Bobo Tong; Lukas Grassner; Frank Bradke; Fred Geisler; John K Kramer
Journal:  CNS Drugs       Date:  2019-05       Impact factor: 5.749

8.  DLK regulates a distinctive transcriptional regeneration program after peripheral nerve injury.

Authors:  Jung Eun Shin; Hongseok Ha; Yoon Ki Kim; Yongcheol Cho; Aaron DiAntonio
Journal:  Neurobiol Dis       Date:  2019-02-05       Impact factor: 5.996

9.  Elevating Growth Factor Responsiveness and Axon Regeneration by Modulating Presynaptic Inputs.

Authors:  Yiling Zhang; Philip R Williams; Anne Jacobi; Chen Wang; Anurag Goel; Arlene A Hirano; Nicholas C Brecha; Daniel Kerschensteiner; Zhigang He
Journal:  Neuron       Date:  2019-05-20       Impact factor: 17.173

Review 10.  The Biology of Regeneration Failure and Success After Spinal Cord Injury.

Authors:  Amanda Phuong Tran; Philippa Mary Warren; Jerry Silver
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.